HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,806 Cr | ₹2,764 Cr | ₹2,385 Cr | ₹2,328 Cr | ₹2,016 Cr |
What is the latest Total Liabilities ratio of HIKAL ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹2,806 Cr |
Mar2024 | ₹2,764 Cr |
Mar2023 | ₹2,385 Cr |
Mar2022 | ₹2,328 Cr |
Mar2021 | ₹2,016 Cr |
How is Total Liabilities of HIKAL Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹2,806 Cr | 1.55 | |
Mar2024 | ₹2,764 Cr | 15.85 | |
Mar2023 | ₹2,385 Cr | 2.47 | |
Mar2022 | ₹2,328 Cr | 15.49 | |
Mar2021 | ₹2,016 Cr | - |
Compare Total Liabilities of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹2,977.1 Cr | 1.2% | -9.6% | -35.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,140.0 Cr | 2.1% | 2.4% | -11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,290.0 Cr | 0.7% | 8.2% | 8.1% | Stock Analytics | |
CIPLA | ₹132,417.0 Cr | 5.6% | 3.9% | 1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,839.0 Cr | 1.5% | 0.1% | 1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,031.0 Cr | 3.7% | -3% | -6.4% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | 1.2% |
-9.6% |
-35.7% |
SENSEX | 2.5% |
2% |
3.1% |
You may also like the below Video Courses